About this document

Sun Pharma Annual Report 2014-15 Overview by debjyoti.karmakar23 is a document available to read on EtoBox.

Sun Pharmaceutical Industries Ltd. is a leading global specialty generic pharmaceutical company, founded in 1983, with a presence in over 100 countries and a focus on various therapeutic areas. As of February 2025, the company has a market capitalization of ₹4,18,552 crore, a low debt-to-equity ratio of 0.05, and a return on equity of 16.7%, indicating strong financial health. The stock is in a steady uptrend with positive technical indicators and strong support levels, making it an attractive investment op

Author

debjyoti.karmakar23

Language

EN